MedPath

MAR-PALIPERIDONE

MAR-PALIPERIDONE

Dormant
DIN Number

02511029

Drug Class

Human

Market Date

Jun 29, 2021

Company
HC

marcan pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02511029
AIG Number0152320002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AX13 PALIPERIDONE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

PALIPERIDONEActive
Strength: 6 MG
Monograph: PALIPERIDONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.